Skip to content

Clinical trials

Medulloblastoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Medulloblastoma Clear all

314 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20009
20018
20029
20036
200410
200514
200610
200710
20088
200911
201015
20117
20124
201312
20147
20159
20167
201716
201814
201914
202012
202111
202211
20236
202410
202510
202616

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed168
Recruiting37
Active, not recruiting31
Terminated31
Unknown status18
Withdrawn13
Not yet recruiting12
No longer available1
Suspended1
Enrolling by invitation1
Available1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)53
Children's Oncology Group18
Pediatric Brain Tumor Consortium16
St. Jude Children's Research Hospital12
Giselle Sholler7
Novartis Pharmaceuticals7
Memorial Sloan Kettering Cancer Center6
National Institutes of Health Clinical Center (CC)6
City of Hope Medical Center5
Duke University5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Medulloblastoma314
Astrocytoma115
Central Nervous System Neoplasms112
Ependymoma112
Glioma106
Brain Neoplasms93
Oligodendroglioma88
Neuroblastoma84
Glioblastoma70
Choroid Plexus Neoplasms69

Trials

Showing 1 to 25 of 314. Each trial links to its page on Pharma Observatory.

214 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.